For: | Theodoropoulos G, Papaconstantinou I, Felekouras E, Nikiteas N, Karakitsos P, Panoussopoulos D, Lazaris AC, Patsouris E, Bramis J, Gazouli M. Relation between common polymorphisms in genes related to inflammatory response and colorectal cancer. World J Gastroenterol 2006; 12(31): 5037-5043 [PMID: 16937502 DOI: 10.3748/wjg.v12.i31.5037] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v12/i31/5037.htm |
Number | Citing Articles |
1 |
Li-Xia Hu, Ying-Ying Du, Ying Zhang, Yue-Yin Pan. Lack of Association Between Interleukin-8-251 T>A Polymorphism and Colorectal Cancer Risk: a Meta-analysis based on 3,019 Cases and 3,984 Controls. Asian Pacific Journal of Cancer Prevention 2012; 13(10): 5075 doi: 10.7314/APJCP.2012.13.10.5075
|
2 |
Sébastien Küry, Bruno Buecher, Sébastien Robiou-du-Pont, Catherine Scoul, Hélène Colman, Tanguy Le Neel, Claire Le Houérou, Roger Faroux, Jean Ollivry, Bernard Lafraise, Louis-Dominique Chupin, Véronique Sébille, Stéphane Bézieau. Low-penetrance alleles predisposing to sporadic colorectal cancers: a French case-controlled genetic association study. BMC Cancer 2008; 8(1) doi: 10.1186/1471-2407-8-326
|
3 |
Zhenkun Fu, Mingli Jiao, Mingyan Zhang, Fengyan Xu, Weiguang Yuan, Da Pang, Dianjun Li. LFA-1 gene polymorphisms are associated with the sporadic infiltrative duct breast carcinoma in Chinese Han women of Heilongjiang Province. Breast Cancer Research and Treatment 2011; 127(1): 265 doi: 10.1007/s10549-010-1203-6
|
4 |
C.C.J.M. Simons, L.J. Schouten, R. Godschalk, M. van Engeland, P.A. van den Brandt, F.J. van Schooten, M.P. Weijenberg. Body size, physical activity, genetic variants in the insulin-like growth factor pathway and colorectal cancer risk. Carcinogenesis 2015; 36(9): 971 doi: 10.1093/carcin/bgv077
|
5 |
Katriina Heikkilä, Ross Harris, Gordon Lowe, Ann Rumley, John Yarnell, John Gallacher, Yoav Ben-Shlomo, Shah Ebrahim, Debbie A. Lawlor. Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis. Cancer Causes & Control 2009; 20(1): 15 doi: 10.1007/s10552-008-9212-z
|
6 |
Xingchun Peng, Jun Shi, Wanqun Sun, Xuzhi Ruan, Yang Guo, Lunhua Zhao, Jue Wang, Bin Li. Genetic polymorphisms of IL-6 promoter in cancer susceptibility and prognosis: a meta-analysis. Oncotarget 2018; 9(15): 12351 doi: 10.18632/oncotarget.24033
|
7 |
Kun-Yun Yeh, Ying-Ying Li, Ling-Ling Hsieh, Jim-Ray Chen, Rei-Ping Tang. The −174 G/C Polymorphism in Interleukin-6 (IL-6) Promoter Region is Associated with Serum IL-6 and Carcinoembryonic Antigen Levels in Patients with Colorectal Cancers in Taiwan. Journal of Clinical Immunology 2010; 30(1): 53 doi: 10.1007/s10875-009-9324-6
|
8 |
Sami Ahmad, Hassan Ashktorab, Hassan Brim, Franck Housseau. Inflammation, microbiome and colorectal cancer disparity in African-Americans: Are there bugs in the genetics?. World Journal of Gastroenterology 2022; 28(25): 2782-2801 doi: 10.3748/wjg.v28.i25.2782
|
9 |
Konstantinos K. Tsilidis, Thomas P. Erlinger, Nader Rifai, Sandy Hoffman, Judy Hoffman-Bolton, Kathy J. Helzlsouer, Elizabeth A. Platz. C-reactive protein and colorectal adenoma in the CLUE II cohort. Cancer Causes & Control 2008; 19(6): 559 doi: 10.1007/s10552-008-9117-x
|
10 |
Constantinos Pantelis Zambirinis, George Theodoropoulos, Maria Gazouli. Undefined familial colorectal cancer. World Journal of Gastrointestinal Oncology 2009; 1(1): 12-20 doi: 10.4251/wjgo.v1.i1.12
|
11 |
Xue Huang, Shanyu Qin, Yongru Liu, Lin Tao, Haixing Jiang. Associations of tumor necrosis factor-α polymorphisms with the risk of colorectal cancer: a meta-analysis. Bioscience Reports 2019; 39(1) doi: 10.1042/BSR20181750
|
12 |
Mohammad Hossein Antikchi, Fatemeh Asadian, Seyed Alireza Dastgheib, Yaser Ghelmani, Shadi Kargar, Jalal Sadeghizadeh-Yazdi, Hossein Neamatzadeh. Cumulative Evidence for Association Between IL-8 -251T>A and IL-18 -607C>A Polymorphisms and Colorectal Cancer Susceptibility: a Systematic Review and Meta-analysis. Journal of Gastrointestinal Cancer 2021; 52(1): 31 doi: 10.1007/s12029-020-00521-w
|
13 |
Manuel Gentiluomo, Giulia Peduzzi, Ye Lu, Daniele Campa, Federico Canzian. Genetic polymorphisms in inflammatory genes and pancreatic cancer risk: a two-phase study on more than 14 000 individuals. Mutagenesis 2019; doi: 10.1093/mutage/gez040
|
14 |
Alexia Klonou, Penelope Korkolopoulou, Antonios N. Gargalionis, Dimitrios S. Kanakoglou, Hector Katifelis, Maria Gazouli, Sarantis Chlamydas, Andreas Mitsios, Theodosis Kalamatianos, George Stranjalis, Marios S. Themistocleous, Kostas A. Papavassiliou, Spyros Sgouros, Athanasios G. Papavassiliou, Christina Piperi. Histone Mark Profiling in Pediatric Astrocytomas Reveals Prognostic Significance of H3K9 Trimethylation and Histone Methyltransferase SUV39H1. Neurotherapeutics 2021; 18(3): 2073 doi: 10.1007/s13311-021-01090-x
|
15 |
Mingqi Li, Qi You, Xishan Wang. Association Between Polymorphism of the Tumor Necrosis Factor Alpha-308 Gene Promoter and Colon Cancer in the Chinese Population. Genetic Testing and Molecular Biomarkers 2011; 15(11): 743 doi: 10.1089/gtmb.2011.0068
|
16 |
Melissa Kang, Temitope O. Keku. Impact of Energy Balance on Cancer Disparities. 2014; : 131 doi: 10.1007/978-3-319-06103-0_7
|
17 |
Sepehr Sadafi, Nasrin Amirifard, Omid Emami Aleagha, Seyed Ghasem Mirbahari, Masoud Sadeghi. A Meta-Analysis of Association Between Interleukin Polymorphisms (rs4073, rs1800925, rs1179251, rs1179246, rs2227485, rs17855750, and rs153109) and Colorectal Cancer Risk. Biochemical Genetics 2024; doi: 10.1007/s10528-024-10969-1
|
18 |
Sudipto Saha, Scott H. Harrison, Jake Yue Chen. Dissecting the human plasma proteome and inflammatory response biomarkers. PROTEOMICS 2009; 9(2): 470 doi: 10.1002/pmic.200800507
|
19 |
Tamara Čačev, Mladen Jokić, Božo Lončar, Šimun Križanac, Sanja Kapitanović. Interleukin-6-174 G/C Polymorphism is Not Associated with IL-6 Expression and Susceptibility to Sporadic Colon Cancer. DNA and Cell Biology 2010; 29(4): 177 doi: 10.1089/dna.2009.0950
|
20 |
Katriina Heikkilä, Shah Ebrahim, Debbie A. Lawlor. Systematic review of the association between circulating interleukin-6 (IL-6) and cancer. European Journal of Cancer 2008; 44(7): 937 doi: 10.1016/j.ejca.2008.02.047
|
21 |
Emma E. Vincent, Hanieh Yaghootkar. Using genetics to decipher the link between type 2 diabetes and cancer: shared aetiology or downstream consequence?. Diabetologia 2020; 63(9): 1706 doi: 10.1007/s00125-020-05228-y
|
22 |
Artemisia Kakourou, Charalampia Koutsioumpa, David S. Lopez, Judith Hoffman-Bolton, Gary Bradwin, Nader Rifai, Kathy J. Helzlsouer, Elizabeth A. Platz, Konstantinos K. Tsilidis. Interleukin-6 and risk of colorectal cancer: results from the CLUE II cohort and a meta-analysis of prospective studies. Cancer Causes & Control 2015; 26(10): 1449 doi: 10.1007/s10552-015-0641-1
|
23 |
JAN DIMBERG, RENATE SLIND OLSEN, MARITA SKARSTEDT, STURE LÖFGREN, NIKLAS ZAR, ANDREAS MATUSSEK. Polymorphism of the p38β gene in patients with colorectal cancer. Oncology Letters 2014; 8(3): 1093 doi: 10.3892/ol.2014.2315
|
24 |
Xiangmin Li, Ming Zhao, Yu-Rong Tang, Chao Wang, Ziding Zhang, Shiqi Peng. N-[2-(5,5-Dimethyl-1,3-dioxane-2-yl)ethyl]amino acids: Their synthesis, anti-inflammatory evaluation and QSAR analysis. European Journal of Medicinal Chemistry 2008; 43(1): 8 doi: 10.1016/j.ejmech.2007.03.015
|
25 |
Megan Dann Fesinmeyer, Janet L. Stanford, Teresa A. Brentnall, Margaret T. Mandelson, Federico M. Farin, Sengkeo Srinouanprachanh, Zahra Afsharinejad, Gary E. Goodman, Matt J. Barnett, Melissa A. Austin. Association Between the Peroxisome Proliferator-Activated Receptor γ Pro12Ala Variant and Haplotype and Pancreatic Cancer in a High-Risk Cohort of Smokers. Pancreas 2009; 38(6): 631 doi: 10.1097/MPA.0b013e3181a53ef9
|
26 |
Martha L. Slattery, Roger K. Wolff, Jennifer S. Herrick, Bette J. Caan, John D. Potter. IL6 genotypes and colon and rectal cancer. Cancer Causes & Control 2007; 18(10): 1095 doi: 10.1007/s10552-007-9049-x
|
27 |
Mujeeb Zafar Banday, Henah Mehraj Balkhi, Zeenat Hamid, Aga Syed Sameer, Nissar A. Chowdri, Ehtishamul Haq. Tumor necrosis factor-α (TNF-α)-308G/A promoter polymorphism in colorectal cancer in ethnic Kashmiri population — A case control study in a detailed perspective. Meta Gene 2016; 9: 128 doi: 10.1016/j.mgene.2016.06.001
|
28 |
Zhiyuan Qiu, Zhiqiang Xie, Rong Qin, Meifang Chen, Han He, Zhao Zhang, Yan Wang, Ming Hong, Weifeng Tang, Yan Xi, Sheng Zhang. Evaluation of ICAM-1 rs5498 and rs3093030 Polymorphisms in Chinese Patients with Colorectal Cancer. DNA and Cell Biology 2021; 40(2): 384 doi: 10.1089/dna.2020.6089
|
29 |
Konstantinos K. Tsilidis, Casey Branchini, Eliseo Guallar, Kathy J. Helzlsouer, Thomas P. Erlinger, Elizabeth A. Platz. C‐reactive protein and colorectal cancer risk: A systematic review of prospective studies. International Journal of Cancer 2008; 123(5): 1133 doi: 10.1002/ijc.23606
|
30 |
Umit Yilmaz, Umit Zeybek, Ozlem Timirci Kahraman, Ali Metin Kafadar, Bahar Toptas, Nesibe Yamak, Faruk Celik, Ilhan Yaylim. Investigation of ICAM-1 and β3 Integrin Gene Variations in Patients with Brain Tumors. Asian Pacific Journal of Cancer Prevention 2013; 14(10): 5929 doi: 10.7314/APJCP.2013.14.10.5929
|
31 |
Callum J. Titmarsh, Sophia M. Moscovis, Sharron Hall, Georgina Tzanakaki, Konstantinos Kesanopoulos, Athanasia Xirogianni, Rodney J. Scott, C. Caroline Blackwell. Comparison of cytokine gene polymorphisms among Greek patients with invasive meningococcal disease or viral meningitis.
Journal of Medical Microbiology
2013; 62(5): 694 doi: 10.1099/jmm.0.058073-0
|
32 |
Alicia Garcia-Anguita, Artemisia Kakourou, Konstantinos K. Tsilidis. Biomarkers of Inflammation and Immune Function and Risk of Colorectal Cancer. Current Colorectal Cancer Reports 2015; 11(5): 250 doi: 10.1007/s11888-015-0282-5
|
33 |
Geng Tian, Jia Mi, Xiaodan Wei, Dongmei Zhao, Lingyan Qiao, Chunhua Yang, Xianglin Li, Shuping Zhang, Xuri Li, Bin Wang. Circulating interleukin-6 and cancer: A meta-analysis using Mendelian randomization. Scientific Reports 2015; 5(1) doi: 10.1038/srep11394
|
34 |
Cheng Chen, Lingyan Wang, Qi Liao, Leiting Xu, Yi Huang, Cheng Zhang, Huadan Ye, Xuting Xu, Meng Ye, Shiwei Duan. Association Between Six Genetic Polymorphisms and Colorectal Cancer: A Meta-Analysis. Genetic Testing and Molecular Biomarkers 2014; 18(3): 187 doi: 10.1089/gtmb.2013.0425
|
35 |
P. Christopoulos, G. Mastorakos, M. Gazouli, E. Deligeoroglou, I. Katsikis, E. Diamanti‐Kandarakis, D. Panidis, G. Creatsas. Peroxisome proliferator‐activated receptor‐γ and ‐δ polymorphisms in women with polycystic ovary syndrome. Annals of the New York Academy of Sciences 2010; 1205(1): 185 doi: 10.1111/j.1749-6632.2010.05647.x
|
36 |
Nargess Arandi, Abdolrasoul Talei, Nasrollah Erfani, Abbas Ghaderi. Intercellular adhesion molecule-1 genetic markers (+241G/A and +469A/G) in Iranian women with breast cancer. Cancer Genetics and Cytogenetics 2008; 183(1): 9 doi: 10.1016/j.cancergencyto.2008.01.019
|
37 |
M. Crous-Bou, G. Rennert, R. Salazar, F. Rodriguez-Moranta, H. S. Rennert, F. Lejbkowicz, L. Kopelovich, S. M. Lipkin, S. B. Gruber, V. Moreno. Genetic polymorphisms in fatty acid metabolism genes and colorectal cancer. Mutagenesis 2012; 27(2): 169 doi: 10.1093/mutage/ger066
|
38 |
Meriam Hazgui, Marwa Weslati, Donia Ounissi, Rahma Boughriba, Dhouha Bacha, Basma Loueslati. Interleukin-1β, interleukin-6 and interleukin-10 polymorphisms in Tunisian patients with colorectal cancer and liver metastasis. Archives of Biological Sciences 2022; 74(4): 333 doi: 10.2298/ABS220607032H
|
39 |
Anna E. Prizment, Kristin E. Anderson, Kala Visvanathan, Aaron R. Folsom. Association of Inflammatory Markers with Colorectal Cancer Incidence in the Atherosclerosis Risk in Communities Study. Cancer Epidemiology, Biomarkers & Prevention 2011; 20(2): 297 doi: 10.1158/1055-9965.EPI-10-1146
|
40 |
Alexa J. Resler, Karen W. Makar, Laura Heath, John Whitton, John D. Potter, Elizabeth M. Poole, Nina Habermann, Dominique Scherer, David Duggan, Hansong Wang, Noralane M. Lindor, Michael N. Passarelli, John A. Baron, Polly A. Newcomb, Loic Le Marchand, Cornelia M. Ulrich. Genetic variation in prostaglandin synthesis and related pathways, NSAID use and colorectal cancer risk in the Colon Cancer Family Registry. Carcinogenesis 2014; 35(9): 2121 doi: 10.1093/carcin/bgu119
|
41 |
Simona Ognjanovic, Jennifer Yamamoto, Barbara Saltzman, Adrian Franke, Miodrag Ognjanovic, Lance Yokochi, Thomas Vogt, Robert Decker, Loïc Le Marchand. Serum CRP and IL-6, genetic variants and risk of colorectal adenoma in a multiethnic population. Cancer Causes & Control 2010; 21(7): 1131 doi: 10.1007/s10552-010-9540-7
|
42 |
Nehad A. El-Sayed, Fadi M. Awadallah, Nashwa A. Ibrahim, Mohammed T. El-Saadi. Synthesis, anti-inflammatory and ulcerogenicity studies of some substituted pyrimido[1,6-a]azepine derivatives. European Journal of Medicinal Chemistry 2010; 45(7): 3147 doi: 10.1016/j.ejmech.2010.04.005
|
43 |
Yonggang Wang, Tianying Zheng. Screening of Hub Genes and Pathways in Colorectal Cancer with Microarray Technology. Pathology & Oncology Research 2014; 20(3): 611 doi: 10.1007/s12253-013-9739-5
|
44 |
Na Wang, Rongmiao Zhou, Chunmei Wang, Xiaoqing Guo, Zhifeng Chen, Shan Yang, Yan Li. −251 T/A polymorphism of the interleukin-8 gene and cancer risk: a HuGE review and meta-analysis based on 42 case–control studies. Molecular Biology Reports 2012; 39(3): 2831 doi: 10.1007/s11033-011-1042-5
|
45 |
Jamal Jafari-Nedooshan, Seyed Alireza Dastgheib, Saeed Kargar, Mohammad Zare, Ali Raee-Ezzabadi, Naeimeh Heiranizadeh, Jalal Sadeghizadeh-Yazdi, Hossein Neamatzadeh. Association of IL-6 −174 G>C Polymorphism with Susceptibility to Colorectal Cancer and Gastric Cancer: a Systematic Review and Meta-Analysis. Acta Medica (Hradec Kralove, Czech Republic) 2019; 62(4): 137 doi: 10.14712/18059694.2020.2
|
46 |
Mujeeb Zafar Banday, Henah Mehraj Balkhi, Aga Syed Sameer, Nissar A Chowdri, Ehtishamul Haq. Strong association of interleukin-6 −174G/C promoter single nucleotide polymorphism with a decreased risk of colorectal cancer in ethnic Kashmiri population: A case control study. Tumor Biology 2017; 39(3): 101042831769594 doi: 10.1177/1010428317695940
|
47 |
Nastaran Bani, Mehrdad Moetamani-Ahmadi, Maryam Alidoust, Soodabeh ShahidSales, Majid Khazaei, Habibollah Esmaily, Mona Joudi-Mashhad, Gordon A. Ferns, Masoumeh Gharib, Amir Avan. Association between the 308 G>A variant of the TNF-α gene and risk of colorectal cancer. Meta Gene 2021; 28: 100878 doi: 10.1016/j.mgene.2021.100878
|
48 |
Inês Guerra de Melo, Valéria Tavares, Deolinda Pereira, Rui Medeiros. Contribution of Endothelial Dysfunction to Cancer Susceptibility and Progression: A Comprehensive Narrative Review on the Genetic Risk Component. Current Issues in Molecular Biology 2024; 46(5): 4845 doi: 10.3390/cimb46050292
|
49 |
Florin Burada, Theodor Dumitrescu, Raluca Nicoli, Marius Eugen Ciurea, Cristina Angelescu, Francisc Mixich, Mihai Ioana. IL-1RN +2018T>C polymorphism is correlated with colorectal cancer. Molecular Biology Reports 2013; 40(4): 2851 doi: 10.1007/s11033-012-2300-x
|
50 |
Mathilde Touvier, Emmanuelle Kesse-Guyot, Valentina A Andreeva, Léopold Fezeu, Nathalie Charnaux, Angela Sutton, Nathalie Druesne-Pecollo, Serge Hercberg, Pilar Galan, Laurent Zelek, Paule Latino-Martel, Sébastien Czernichow. Modulation of the association between plasma intercellular adhesion molecule-1 and cancer risk by n-3 PUFA intake: a nested case-control study. The American Journal of Clinical Nutrition 2012; 95(4): 944 doi: 10.3945/ajcn.111.027805
|
51 |
Renate S. Olsen, Roland E. Andersson, Niklas Zar, Sture Löfgren, Dick Wågsäter, Andreas Matussek, Jan Dimberg. Prognostic significance of PLA2G4C gene polymorphism in patients with stage II colorectal cancer. Acta Oncologica 2016; 55(4): 474 doi: 10.3109/0284186X.2015.1073350
|
52 |
Kristina L. Bondurant, Abbie Lundgreen, Jennifer S. Herrick, Susan Kadlubar, Roger K. Wolff, Martha L. Slattery. Interleukin genes and associations with colon and rectal cancer risk and overall survival. International Journal of Cancer 2013; 132(4): 905 doi: 10.1002/ijc.27660
|
53 |
Xiyong Bai. Effect of Proliferator-Activated Receptor-γ Pro12Ala Polymorphism on Colorectal Cancer Risk: A Meta-Analysis. Medical Science Monitor 2015; 21: 1611 doi: 10.12659/MSM.892849
|
54 |
Ziliang Wang, Yang Liu, Lina Yang, Sheng Yin, Rongyu Zang, Gong Yang. The polymorphism interleukin-8 -251A/T is associated with a significantly increased risk of cancers from a meta-analysis. Tumor Biology 2014; 35(7): 7115 doi: 10.1007/s13277-014-1881-5
|
55 |
Niloofar Darvishi, Nader Salari, Shadi Bokaee, Shamarina Shohaimi, Masoud Mohammadi. The Effect of IL-6 174G > C Gene Polymorphism on Gastrointestinal Cancer: a Systematic Review and Meta-analysis. Indian Journal of Surgical Oncology 2023; 14(2): 411 doi: 10.1007/s13193-022-01698-1
|
56 |
Lin-Bo Gao, Xin-Min Pan, Jing Jia, Wei-Bo Liang, Li Rao, Hui Xue, Yi Zhu, Shi-Liu Li, Mei-Li Lv, Wei Deng, Tian-Yi Chen, Yong-Gang Wei, Lin Zhang. IL-8 –251A/T polymorphism is associated with decreased cancer risk among population-based studies: Evidence from a meta-analysis. European Journal of Cancer 2010; 46(8): 1333 doi: 10.1016/j.ejca.2010.03.011
|
57 |
RENG-YUN LIU, XIAOXUE SONG, PING CHEN, ZHE LEI, JINGCHENG MIAO, NENGJUN YI, KUI ZHANG, BORIS PASCHE, HONG-TAO ZHANG. Association between IL6 -174G/C and cancer: A meta-analysis of 105,482 individuals. Experimental and Therapeutic Medicine 2012; 3(4): 655 doi: 10.3892/etm.2012.454
|
58 |
Hannelien Verbeke, Sofie Struyf, Geneviève Laureys, Jo Van Damme. The expression and role of CXC chemokines in colorectal cancer. Cytokine & Growth Factor Reviews 2011; 22(5-6): 345 doi: 10.1016/j.cytogfr.2011.09.002
|
59 |
Theoharis C. Theoharides, Jacek J. Rozniecki, Gary Sahagian, Stanley Jocobson, Duraisamy Kempuraj, Pio Conti, Dimitris Kalogeromitros. Impact of stress and mast cells on brain metastases. Journal of Neuroimmunology 2008; 205(1-2): 1 doi: 10.1016/j.jneuroim.2008.09.014
|
60 |
Lin Liu, Meili Sun, Degang Song, Zhehai Wang. The genetic polymorphisms of intercellular cell adhesion molecules and breast cancer susceptibility: a meta-analysis. Molecular Biology Reports 2013; 40(2): 1855 doi: 10.1007/s11033-012-2241-4
|
61 |
Statistical meta-analysis to investigate the association between the Interleukin-6 (IL-6) gene polymorphisms and cancer risk. PLOS ONE 2021; 16(3): e0247055 doi: 10.1371/journal.pone.0247055
|
62 |
Thao Pham, Pascal Claudepierre, Arnaud Constantin, Michel de Bandt, Bruno Fautrel, Laure Gossec, Jacques-Eric Gottenberg, Philippe Goupille, Séverine Guillaume, Eric Hachulla, Charles Masson, Jacques Morel, Xavier Puéchal, Alain Saraux, Thierry Schaeverbeke, Daniel Wendling, Eric Bruckert, Stanislas Pol, Xavier Mariette, Jean Sibilia. Tocilizumab: Therapy and safety management. Joint Bone Spine 2010; 77: S3 doi: 10.1016/S1297-319X(10)70001-4
|
63 |
Wang Fan, Wang Maoqing, Chen Wangyang, Hu Fulan, Li Dandan, Ren Jiaojiao, Dong Xinshu, Cui Binbin, Zhao Yashuang. Relationship between the polymorphism of tumor necrosis factor-α-308 G>A and susceptibility to inflammatory bowel diseases and colorectal cancer: a meta-analysis. European Journal of Human Genetics 2011; 19(4): 432 doi: 10.1038/ejhg.2010.159
|
64 |
Hao Ding, Yuanmei Chen, Hao Qiu, Chao Liu, Yafeng Wang, Mingqiang Kang, Weifeng Tang. PPARG c.1347C>T polymorphism is associated with cancer susceptibility: from a case-control study to a meta-analysis. Oncotarget 2017; 8(60): 102277 doi: 10.18632/oncotarget.20925
|
65 |
Konstantinos K. Tsilidis, Kathy J. Helzlsouer, Michael W. Smith, Victoriya Grinberg, Judith Hoffman-Bolton, Sandra L. Clipp, Kala Visvanathan, Elizabeth A. Platz. Association of common polymorphisms in IL10, and in other genes related to inflammatory response and obesity with colorectal cancer. Cancer Causes & Control 2009; 20(9): 1739 doi: 10.1007/s10552-009-9427-7
|
66 |
Konstantina Vogiatzi, Stavros Apostolakis, Vassilios Voudris, Sophia Thomopoulou, Georgios E. Kochiadakis, Demetrios A. Spandidos. Interleukin 8 and Susceptibility to Coronary Artery Disease: a Population Genetics Perspective.. Journal of Clinical Immunology 2008; 28(4): 329 doi: 10.1007/s10875-008-9194-3
|
67 |
T. Cacev, S. Radosevic, S. Krizanac, S. Kapitanovic. Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression. Carcinogenesis 2008; 29(8): 1572 doi: 10.1093/carcin/bgn164
|
68 |
Weimin He, Marie-Claude Vohl. PPARγ2Pro12Ala Polymorphism and Human Health. PPAR Research 2009; 2009(1) doi: 10.1155/2009/849538
|
69 |
Shian-Shiang Wang, Ming-Ju Hsieh, Yen-Chuan Ou, Chuan-Shu Chen, Jian-Ri Li, Pei-Ching Hsiao, Shun-Fa Yang. Impacts of ICAM-1 gene polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic characteristics in Taiwan. Tumor Biology 2014; 35(8): 7483 doi: 10.1007/s13277-014-1934-9
|
70 |
E. Karamitopoulou, M. Shoni, T.C. Theoharides. Increased Number of Non-Degranulated Mast Cells in Pancreatic Ductal Adenocarcinoma but Not in Acute Pancreatitis. International Journal of Immunopathology and Pharmacology 2014; 27(2): 213 doi: 10.1177/039463201402700208
|
71 |
S. Wilkening, B. Tavelin, F. Canzian, K. Enquist, R. Palmqvist, A. Altieri, G. Hallmans, K. Hemminki, P. Lenner, A. Forsti. Interleukin promoter polymorphisms and prognosis in colorectal cancer. Carcinogenesis 2008; 29(6): 1202 doi: 10.1093/carcin/bgn101
|
72 |
Martha L. Slattery, Roger K. Wolff, Karen Curtin, Frank Fitzpatrick, Jennifer Herrick, John D. Potter, Bette J. Caan, Wade S. Samowitz. Colon tumor mutations and epigenetic changes associated with genetic polymorphism: Insight into disease pathways. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2009; 660(1-2): 12 doi: 10.1016/j.mrfmmm.2008.10.001
|
73 |
Noyko Stanilov, Lyuba Miteva, Zlatka Dobreva, Spaska Stanilova. Colorectal cancer severity and survival in correlation with tumour necrosis factor-alpha. Biotechnology & Biotechnological Equipment 2014; 28(5): 911 doi: 10.1080/13102818.2014.965047
|
74 |
Jan Dimberg, Marita Skarstedt, Renate Slind Olsen, Roland E. Andersson, Andreas Matussek. Gene polymorphism in DNA repair genes XRCC1 and XRCC6 and association with colorectal cancer in Swedish patients. APMIS 2016; 124(9): 736 doi: 10.1111/apm.12563
|
75 |
Eirini Thanopoulou, George Kotzamanis, Ioannis S. Pateras, Nicholaos Ziras, Alexandros Papalambros, Theodoros Mariolis-Sapsakos, Fragiska Sigala, Elizabeth Johnson, Athanassios Kotsinas, Andreas Scorilas, Vassilis G. Gorgoulis. The single nucleotide polymorphism g.1548A >G (K469E) of the ICAM-1 gene is associated with worse prognosis in non-small cell lung cancer. Tumor Biology 2012; 33(5): 1429 doi: 10.1007/s13277-012-0393-4
|
76 |
Qurteeba Qadri, Roohi Rasool, Dil Afroze, Sameer Naqash, G. M. Gulzar, Adfar Yousuf, M. A. Siddiqi, Zafar A. Shah. Study of TLR4 and IL-8 Gene Polymorphisms inH.pylori-Induced Inflammation in Gastric Cancer in an Ethnic Kashmiri Population. Immunological Investigations 2014; 43(4): 324 doi: 10.3109/08820139.2013.854378
|
77 |
V. V. Novikov, S. V. Shumilova, D. V. Novikov, A. V. Kalugin, S. G. Fomina, A. V. Karaulov. Genetic Instability in Locus rs5498 E469K (A/G) of ICAM-1 Gene in Patients with Colorectal Cancer and Breast Cancer. Bulletin of Experimental Biology and Medicine 2016; 160(6): 811 doi: 10.1007/s10517-016-3316-3
|
78 |
Sami Ahmad, Hassan Ashktorab, Hassan Brim, Franck Housseau. Inflammation, microbiome and colorectal cancer disparity in African-Americans: Are there bugs in the genetics?. World Journal of Gastroenterology 2022; 28(25): 2783 doi: 10.3748/wjg.v28.i25.2783
|
79 |
Hansong Wang, Darin Taverna, Daniel O. Stram, Barbara K. Fortini, Iona Cheng, Lynne R. Wilkens, Terrilea Burnett, Karen W. Makar, Noralane M. Lindor, John L. Hopper, Steve Gallinger, John A. Baron, Robert Haile, Laurence N. Kolonel, Brian E. Henderson, Polly A. Newcomb, Graham Casey, David Duggan, Cornelia M. Ulrich, Loïc Le Marchand. Genetic Variation in the Inflammation and Innate Immunity Pathways and Colorectal Cancer Risk. Cancer Epidemiology, Biomarkers & Prevention 2013; 22(11): 2094 doi: 10.1158/1055-9965.EPI-13-0694
|
80 |
Zhiyuan Qiu, Yan Wang, Zhao Zhang, Rong Qin, Yong Peng, Weifeng Tang, Yan Xi, Guangyu Tian, Yeqing Zhang. Roles of intercellular cell adhesion molecule-1 (ICAM-1) in colorectal cancer: expression, functions, prognosis, tumorigenesis, polymorphisms and therapeutic implications. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1052672
|
81 |
Li Min, Duo Chen, Like Qu, Chengchao Shou, Giuseppe Novelli. Tumor Necrosis Factor-A Polymorphisms and Colorectal Cancer Risk: A Meta-Analysis. PLoS ONE 2014; 9(1): e85187 doi: 10.1371/journal.pone.0085187
|
82 |
Álvaro H. Borges, Michael J. Silverberg, Deborah Wentworth, Andrew E. Grulich, Gerd Fätkenheuer, Ronald Mitsuyasu, Giuseppe Tambussi, Caroline A. Sabin, James D. Neaton, Jens D. Lundgren. Predicting risk of cancer during HIV infection. AIDS 2013; 27(9): 1433 doi: 10.1097/QAD.0b013e32835f6b0c
|
83 |
Yong Yu, Wenjun Wang, Song Zhai, Shuangsuo Dang, Mingzhu Sun. IL6 gene polymorphisms and susceptibility to colorectal cancer: a meta-analysis and review. Molecular Biology Reports 2012; 39(8): 8457 doi: 10.1007/s11033-012-1699-4
|
84 |
Colinda C. J. M. Simons, Leo J. Schouten, Roger W. L. Godschalk, Manon van Engeland, Piet A. van den Brandt, Frederik J. van Schooten, Matty P. Weijenberg. Genetic Variants in the Insulin-like Growth Factor Pathway and Colorectal Cancer Risk in the Netherlands Cohort Study. Scientific Reports 2015; 5(1) doi: 10.1038/srep14126
|
85 |
Satoshi Matsusaka, Diana L. Hanna, Shu Cao, Wu Zhang, Dongyun Yang, Yan Ning, Yu Sunakawa, Satoshi Okazaki, Martin D. Berger, Yuji Miyamato, Anish Parekh, Sebastian Stintzing, Fotios Loupakis, Heinz-Josef Lenz. Prognostic Impact of IL6 Genetic Variants in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab-Based Chemotherapy. Clinical Cancer Research 2016; 22(13): 3218 doi: 10.1158/1078-0432.CCR-15-2422
|
86 |
Levar Shamoun, Marita Skarstedt, Roland E. Andersson, Dick Wågsäter, Jan Dimberg. Association study on IL-4, IL-4Rα and IL-13 genetic polymorphisms in Swedish patients with colorectal cancer. Clinica Chimica Acta 2018; 487: 101 doi: 10.1016/j.cca.2018.09.024
|
87 |
Janina Suchy, Ewa Kłujszo-Grabowska, Józef Kładny, Cezary Cybulski, Dominika Wokołorczyk, Jolanta Szymańska-Pasternak, Grzegorz Kurzawski, Rodney J Scott, Jan Lubiński. Inflammatory response gene polymorphisms and their relationship with colorectal cancer risk. BMC Cancer 2008; 8(1) doi: 10.1186/1471-2407-8-112
|
88 |
L. Miteva, N. Stanilov, T. Deliysky, N. Mintchev, S. Stanilova. Association of Polymorphisms in Regulatory Regions of Interleukin-12p40 Gene and Cytokine Serum Level with Colorectal Cancer. Cancer Investigation 2009; 27(9): 924 doi: 10.3109/07357900902918486
|
89 |
Shuwei Wang, Weidong Zhang. Genetic variants in IL-6/JAK/STAT3 pathway and the risk of CRC. Tumor Biology 2016; 37(5): 6561 doi: 10.1007/s13277-015-4529-1
|
90 |
Anna Vašků, Jiří Vokurka, Julie Bienertová-Vašků. Obesity-related genes variability in Czech patients with sporadic colorectal cancer: preliminary results. International Journal of Colorectal Disease 2009; 24(3): 289 doi: 10.1007/s00384-008-0553-6
|
91 |
Linghui Zhou, Yi Zheng, Tian Tian, Kang Liu, Meng Wang, Shuai Lin, Yujiao Deng, Cong Dai, Peng Xu, Qian Hao, Huafeng Kang, Zhijun Dai. Associations of interleukin-6 gene polymorphisms with cancer risk: Evidence based on 49,408 cancer cases and 61,790 controls. Gene 2018; 670: 136 doi: 10.1016/j.gene.2018.05.104
|
92 |
Fevziye Emin Akman, Müge Kanmaz-Özer, Pervin Vural, Ayşenur Özderya, Berrin Karadağ, Semra Doğru-Abbasoğlu, Müjdat Uysal. G241R and K469E polymorphisms of intercellular adhesion molecule 1 (ICAM-1) could predispose to Hashimoto thyroiditis. Molecular Biology Reports 2012; 39(12): 10723 doi: 10.1007/s11033-012-1963-7
|
93 |
Anna Walczak, Karolina Przybylowska, Lukasz Dziki, Andrzej Sygut, Cezary Chojnacki, Jan Chojnacki, Adam Dziki, Ireneusz Majsterek. ThelL-8andIL-13Gene Polymorphisms in Inflammatory Bowel Disease and Colorectal Cancer. DNA and Cell Biology 2012; 31(8): 1431 doi: 10.1089/dna.2012.1692
|
94 |
Hongwei Tang, Xiaoqun Dong, Manal Hassan, James L. Abbruzzese, Donghui Li. Body Mass Index and Obesity- and Diabetes-Associated Genotypes and Risk for Pancreatic Cancer. Cancer Epidemiology, Biomarkers & Prevention 2011; 20(5): 779 doi: 10.1158/1055-9965.EPI-10-0845
|
95 |
Xuemin Liang, Xiaohua Fan, Kanglian Tan, Li Zhang, Lisi Jian, Linchong Yu. Peroxisome proliferators-activated receptor gamma polymorphisms and colorectal cancer risk. Journal of Cancer Research and Therapeutics 2018; 14(Suppl 2): S306 doi: 10.4103/0973-1482.235346
|
96 |
Raju K. Mandal, Munawwar Ali Khan, Arif Hussain, Naseem Akhter, Arshad Jawed, Sajad A. Dar, Mohd Wahid, Aditya K. Panda, Mohtashim Lohani, Bhartendu N. Mishra, Shafiul Haque. A trial sequential meta-analysis ofTNF-α –308G>A (rs800629) gene polymorphism and susceptibility to colorectal cancer. Bioscience Reports 2019; 39(1) doi: 10.1042/BSR20181052
|
97 |
Chia-Wen Tsai, Wen-Shin Chang, Te-Cheng Yueh, Yun-Chi Wang, Yu-Ting Chin, Mei-Due Yang, Yi-Chih Hung, Mei-Chin Mong, Ya-Chen Yang, Jian Gu, Da-Tian Bau. The Significant Impacts of Interleukin-8 Genotypes on the Risk of Colorectal Cancer in Taiwan. Cancers 2023; 15(20): 4921 doi: 10.3390/cancers15204921
|